SREBF1 and fatty liver disease: Conversely, pAMPKα attenuates hepatic steatosis by phosphorylating Ser372 on SREBP-1c in order to inhibit cleavage of precursor SREBP-1c to a transcriptionally active, mature SREBP-1c [33].